Dartmouth-Hitchcock logo
Back
 
C. Everett Koop Lecture: Medicine Grand Rounds - “Medical Marijuana”: What We Know and Don’t Know

Dr. Budney reviews the complexities surrounding the legality, misinformation, product lines, research, potency, and potential of marijuana. He posits that “medical marijuana” is a misnomer since the same products are used as recreational marijuana, and emphasizes that regardless of the intended use, products must be standardized to potency, dose and route of administration in order to mitigate harm and maximize benefit. Many of the conditions and disorders that have been approved as appropriate for use of “medical marijuana” include those that make individuals vulnerable to developing a substance abuse disorder, and many of the products being sold have a high risk for adverse consequences, including addiction, related to high potency. Using science and common sense, cannabis regulatory science and policy are needed to help keep industry impact under control, and to protect the public and vulnerable populations.

Activity Details

Start Date:  September 27, 2019
End Date:  September 27, 2021

You may claim CME credit for successful completion of this online course. In order to claim credit, you must follow these steps:

  1. Register for the learning activity by creating an account or logging in to your account.
  2. Click Continue to navigate to the Activity Material tab. Click View Presentation to view the recording. View the entire presentation.
  3. Return to this Activity page.
  4. Click Continue to navigate to the Evaluation tab; then click the Launch button to start the evaluation.
  5. Complete and Submit the evaluation and attestation form.

When the evaluation is submitted, you will be awarded credit. You may access your transcript for verification of participation at any time via Your Account. Need help? Visit the Support Page, send an Email, or call the Center for Learning and Professional Development at (603) 653-1234, Option 1.

Presenter
  • Alan J. Budney, PhD
    Professor of Psychiatry
    Geisel School of Medicine at Dartmouth
    Center for Technology and Behavioral Health

    Dr. Budney directs a NIDA-funded training program on the Science of Co-Occurring Disorders, and is Director of the Treatment Development and Evaluation Core of Dartmouth's Center for Technology and Behavioral Health.  He has conducted extensive research on innovative behavioral treatments for Cannabis Use Disorders in adults and adolescents.  Dr. Budney has also conducted human laboratory and survey studies characterizing cannabis use, addiction, and withdrawal, and has recently been interested in using social media platforms to assess the impact of the changing legal landscape of cannabis.
Learning Outcome

Participants will be able to describe and discuss the potential impact of medical marijuana, discuss the limitations of the evidence regarding the use of cannabis products to treat physical and mental health disorders, and determine key questions to ask when presented with data and assertions about potential therapeutic effects of cannabis.

Accreditation

Dartmouth-Hitchcock is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Dartmouth-Hitchcock designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Requirements for Successful Completion

In order to receive credit for this Continuing Medical Education (CME) activity, you must:

  • View the entire presentation
  • Complete the online Attestation of Attendance & Evaluation Form (you must register to access).
Disclosure

In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.

The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for C. Everett Koop Lecture: “Medical Marijuana”: What We Know and Don’t Know (Medicine Grand Rounds) have reported the following financial interest or relationship* with various companies/organizations. The Activity Director and Planning Committee member roles were resolved by altering the individual’s control over content about the products or services of the commercial interest by the Associate Dean for CME and the Department of Medicine Chair. All potential conflict(s) were resolved.


* Kelly Kieffer, MD ~ her spouse is a consultant for OcculoBio. 

* Richard I. Rothstein, MD ~ has research support from Baranova (research grant to Dartmouth-Hitchcock Medical Center) and has other financial interest from Allurion. 


Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.

*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.

Provider Contact Information

Provider contact information for questions regarding accreditation of the activity:

Center for Learning and Professional Development
Dartmouth-Hitchcock Medical Center
clpd.support@hitchcock.org


Type:     Internet Activity (Enduring Material)
26 Registered Users

0